Gene Biotherapeutics Inc
OTC:CRXM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gene Biotherapeutics Inc
OTC:CRXM
|
US |
|
Bpost SA
XBRU:BPOST
|
BE |
|
R
|
Roquefort Therapeutics PLC
LSE:ROQ
|
UK |
|
Transcoal Pacific Tbk PT
IDX:TCPI
|
ID |
|
T
|
Teikoku Sen-I Co Ltd
TSE:3302
|
JP |
|
S
|
Svenska Aerogel Holding AB (publ)
STO:AERO
|
SE |
|
Fairwood Holdings Ltd
HKEX:52
|
HK |
|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
US |
|
Tsubakimoto Kogyo Co Ltd
TSE:8052
|
JP |
|
P
|
Procorp SAB de CV
BMV:PROCORPB
|
MX |
Dividends
Dividend Yield
Gene Biotherapeutics Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Gene Biotherapeutics Inc
CRXM have
decreased
by 0%.
Payout Ratio
Gene Biotherapeutics Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for CRXM is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CRXM Price
Gene Biotherapeutics Inc
| Average Annual Return | -49.9% |
| Standard Deviation of Annual Returns | 70.57% |
| Max Drawdown | -100% |
| Market Capitalization | 64.9 USD |
| Shares Outstanding | 649 319 |
| Percentage of Shares Shorted | 1.78% |
CRXM Return Decomposition
Main factors of price return
Stock Splits
CRXM's latest stock split occurred on Jul 18, 2013
The company executed a 1-for-20 stock split, meaning that for every 20 shares held, investors received 1 new share.
Before the split, CRXM traded at 0.066 per share. Afterward, the share price was about 1.349.
The adjusted shares began trading on Jul 18, 2013. This was the only stock split in CRXM's history.
